Zusammenfassung
Im Gegensatz zu den kognitiven Leistungseinschränkungen von Kindern mit Neurofibromatose
Typ I (NF1) ist über das Leistungsprofil erwachsener NF1-Patienten nur wenig bekannt.
Wir unterzogen deshalb eine Gruppe von 20 NF1-Patienten im Alter von 22 bis 61 Jahren
einer ausführlichen psychometrischen Untersuchung und verglichen die Befunde mit denen
neurologisch unauffälliger orthopädischer Patienten. Die Ergebnisse bestätigten die
von den NF1-Kindern gut bekannte Leistungsverschiebung in den unteren Normbereich.
Auch im direkten Vergleich lagen die NF1-Patienten z. T. deutlich unter dem Leistungsniveau
der Kontrollpatienten, ohne jedoch ein spezifisches Störungsprofil aufzuweisen. Wir
werten dies als Hinweis darauf, dass die bei Kindern nachweisbaren kognitiven Defizite
ins Erwachsenenalter tradiert werden.
Abstract
Cognitive impairment is a common phenomenon in children with neurofibromatosis type
1 (NF1), but only little is known about its nature and frequency in adult NF1-patients.
Using a comprehensive psychometric test battery, we investigated 20 patients with
NF1 and 20 age and gender matched control subjects without neurological diseases.
Results showed slightly lowered test scores in patients compared with controls but
no specific intellectual impairment. On a computerized test of selective attention,
the NF1-group had significant slower reaction times. Also, three out of four memory
tests and a test of visuoconstructive abilities showed poorer test results in the
NF1-patients. Executive functions however were not affected. The findings agreed well
with the test profile in NF1-children and supported the idea of a continuum between
childhood and adulthood. Observations are discussed in the context of studies investigating
the association of cognitive deficits with either intracranial lesions or alterations
in the neurofibromin expression.
Literatur
1
Silva A J, Frankland P W, Marowitz Z, Friedman E, Lazlo G, Cioffi D, Jacks T, Bourtchuladze R.
A mouse model for the learning and memory deficits associated with neurofibromatosis
type I.
Nat Genet.
1997;
15
281-284
2
Spaepen A, Borghgraef M, Fryns J P.
Von Recklinghausen-neurofibromatosis: a study of the psychological profile.
Birth Defects Orig Artic Ser.
1992;
28
85-91
3
Creange A, Zeller J, Rostaing-Rigattieri S, Brugieres P, Degos J D, Revuz J, Wolkenstein P.
Neurological complications of neurofibromatosis type 1 in adulthood.
Brain.
1999;
122
473-481
4
Legius E, Descheemaeker M J, Spaepen A, Casaer P, Fryns J P.
Neurofibromatosis type 1 in childhood: a study of the neuropsychological profile in
45 children.
Genet Couns.
1994;
5
51-60
5
North K.
Neurofibromatosis type 1.
Am J Med Genet.
2000;
97
119-127
6
North K N, Joy P, Yuille D, Cocks N, Mobbs E, Hutchins P, McHugh K, de Silva M.
Specific learning disability in children with neurofibromatosis type 1: significance
of MRI abnormalities.
Neurology.
1994;
44
878-883
7
Ozonoff S.
Cognitive impairment in neurofibromatosis type 1.
Am J Med Genet.
1999;
89
45-52
8
Mouridsen S E, Sorensen S A.
Psychological aspects of von Recklinghausen neurofibromatosis (NF1).
J Med Genet.
1995;
32
921-924
9
Dilts C V, Carey J C, Kircher J C, Hoffman R O, Creel D, Ward K, Clark E, Leonard C O.
Children and adolescents with neurofibromatosis 1: a behavioral phenotype.
J Dev Behav Pediatr.
1996;
17
229-239
10
North K N, Riccardi V, Samango-Sprouse C, Ferner R, Moore B, Legius E, Ratner N, Denckla M B.
Cognitive function and academic performance in neurofibromatosis. 1: consensus statement
from the NF1 Cognitive Disorders Task Force.
Neurology.
1997;
48
1121-1127
11
Riccardi V M.
Type 1 neurofibromatosis and the pediatric patient.
Curr Probl Pediatr.
1992;
22
66-107
12
Ferner R E, Hughes R A, Weinman J.
Intellectual impairment in neurofibromatosis 1.
J-Neurol-Sci.
1996;
138
125-133
13
Zöller M E, Rembeck B, Bäckman L.
Neuropsychological deficits in adults with neurofibromatosis type 1.
Acta Neurol Scand.
1997;
95
225-232
14
Mautner V F, Schneider E, Fabra M, Laute S, Funsterer C, Pressler M.
Klinische Bedeutung signalintenser Herde in der zerebralen Magnetresonanztomographie
bei Neurofibromatose.
Fortschr Neurol Psychiatr.
1991;
59
25-30
15 Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP), Version 1.02c. Herzogenrath:
Psytest 1993
16
von Cramon D Y, Hebel N, Schuri U.
Verbal memory and learning in unilateral posterior cerebral infarction. A report on
30 cases.
Brain.
1988;
111
1061-1077
17 Schmidt K H, Metzler P. Wortschatztest (WST). Weinheim: Beltz Test GmbH 1992
18
Eliason M.
Neuropsychological patterns: neurofibromatosis compared to developmental learning
disorders.
Neurofibromatosis.
1988;
1
17-25
19
Mazzocco M M, Turner J E, Denckla M B, Hofman K J, Scanlon D C, Vellutino F R.
Language and reading deficits associated with NF1: evidence for not-so-nonverbal learning
disability.
Dev Neurosci.
1995;
11
503-522
20
Gutmann D H.
Learning disabilities in neurofibromatosis 1: sizing up the brain.
Arch Neurol.
1999;
56
1322-1323
21
Danek A, Wahllander-Danek U, Stenglein-Krapf G, Uttner I.
Neurofibromatose Typ I. Ein Modell für die Untersuchung molekularer Grundlagen von
Kognition.
Nervenarzt.
2001;
72
963-967
22 Feldmann E, Denecke J, Pietsch M, Kurlemann G, Debus O, Schuierer G, Weglage J.
Neurofibromatose Typ 1: MRT-Befunde und kognitive Defizite. Abstract, 15. Jahrestagung
der Gesellschaft für Neuropsychologie. Leipzig 5.-8. 10. 2000
23
Hofman K J, Harris E L, Bryan R N, Denckla M B.
Neurofibromatosis type 1: the cognitive phenotype.
J Pediatr.
1994;
124
S1-8
24
Joy P, Roberts C, North K, de Silva .
Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.
Dev Med Child Neurol.
1995;
37
906-914
25
DiMario Jr F J, Ramsby G R, Burleson J A.
Brain morphometric analysis in neurofibromatosis 1.
Arch Neurol.
1999;
56
1343-1346
26
Ferner R E, Chaudhuri R, Bingham J, Cox T, Hughes R A.
MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted
lesions and their relationship to intellectual impairment.
J Neurol Neurosurg Psychiatry.
1993;
56
492-495
27
Legius E, Descheemaeker M J, Steyaert J, Spaepen A, Vlietinck R, Casaer P, Demaerel P,
Fryns J P.
Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence.
J Neurol Neurosurg Psychiatry.
1995;
59
638-640
28
Weiss B, Bollag G, Shannon K.
Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
Am J Med Genet.
1999;
89
14-22
29
Moore 3rd B D, Slopis J M, Jackson E F, De Winter A E, Leeds N E.
Brain volume in children with neurofibromatosis type 1: relation to neuropsychological
status.
Neurology.
2000;
54
914-920
30
Said S M, Yeh T L, Greenwood R S, Whitt J K, Tupler L A, Krishnan K R.
MRI morphometric analysis and neuropsychological function in patients with neurofibromatosis.
Neuroreport.
1996;
7
1941-1944
31
Brewer V R, Moore 3rd B D, Hiscock M.
Learning disability subtypes in children with neurofibromatosis.
J Learn Disabil.
1997;
30
521-533
Dr. Ingo Uttner
Neurologische Klinik der Universität Ulm, · Bereich RKU
Oberer Eselsberg 45
89081 Ulm
Email: ingo.uttner@medizin.uni-ulm.de